ZVSA
ZyVersa Therapeutics
ZVSA
ZVSA
Delisted
ZVSA was delisted on the 16th of July, 2025.
7 hedge funds and large institutions have $43.9K invested in ZyVersa Therapeutics in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
UBS Group
Zurich,
Switzerland
|
+$15.2K |
2 |
Geode Capital Management
Boston,
Massachusetts
|
+$13.6K |
3 |
Bank of America
Charlotte,
North Carolina
|
+$1 |
Top Sellers
1 |
Citigroup
New York
|
-$37.1K |
2 |
Renaissance Technologies
New York
|
-$13.7K |
3 |
VF
Virtu Financial
New York
|
-$4.85K |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$835 |